688799 华纳药厂
交易中 06-04 13:50:14
资讯
新帖
简况
华纳药厂(688799)披露子公司原料药获得上市申请批准通知书,6月3日股价上涨0.81%
证券之星 · 06-03 17:44
华纳药厂(688799)披露子公司原料药获得上市申请批准通知书,6月3日股价上涨0.81%
华纳药厂(688799.SH)子公司原料药荧光素钠获得上市申请批准通知书
智通财经 · 06-02 16:55
华纳药厂(688799.SH)子公司原料药荧光素钠获得上市申请批准通知书
6月2日华纳药厂跌6.87%,安信医药健康股票A基金重仓该股
证券之星 · 06-02 16:35
6月2日华纳药厂跌6.87%,安信医药健康股票A基金重仓该股
华纳药厂(688799)披露2025年年度股东会决议公告,6月1日股价上涨0.06%
证券之星 · 06-01 17:50
华纳药厂(688799)披露2025年年度股东会决议公告,6月1日股价上涨0.06%
华纳药厂(688799.SH):法罗培南钠片获得药品注册证书
智通财经 · 06-01 16:51
华纳药厂(688799.SH):法罗培南钠片获得药品注册证书
每周股票复盘:华纳药厂(688799)2025年年度股东会各项议案均获通过
证券之星 · 05-31
每周股票复盘:华纳药厂(688799)2025年年度股东会各项议案均获通过
每周股票复盘:华纳药厂(688799)获贝前列素钠片注册证
证券之星 · 05-24
每周股票复盘:华纳药厂(688799)获贝前列素钠片注册证
华纳药厂(688799.SH):贝前列素钠片获得药品注册证书
智通财经 · 05-22
华纳药厂(688799.SH):贝前列素钠片获得药品注册证书
华纳药厂(688799.SH)子公司通过药品GMP符合性检查
智通财经 · 05-22
华纳药厂(688799.SH)子公司通过药品GMP符合性检查
华纳药厂(688799)披露2025年年度股东会变更会议召开地点的公告,5月21日股价下跌2.55%
证券之星 · 05-21
华纳药厂(688799)披露2025年年度股东会变更会议召开地点的公告,5月21日股价下跌2.55%
华纳药厂(688799)披露为全资孙公司提供担保的进展公告,5月14日股价下跌3.31%
证券之星 · 05-14
华纳药厂(688799)披露为全资孙公司提供担保的进展公告,5月14日股价下跌3.31%
每周股票复盘:华纳药厂(688799)子公司原料药获上市批准
证券之星 · 05-10
每周股票复盘:华纳药厂(688799)子公司原料药获上市批准
5月8日华纳药厂涨6.88%,安信医药健康股票A基金重仓该股
证券之星 · 05-08
5月8日华纳药厂涨6.88%,安信医药健康股票A基金重仓该股
华纳药厂终止向实控人方不超2.5亿定增 首季净利降35%
中金财经 · 04-21
华纳药厂终止向实控人方不超2.5亿定增 首季净利降35%
华纳药厂(688799.SH)发布一季度业绩,归母净利润2688万元,同比下降34.79%
智通财经 · 04-20
华纳药厂(688799.SH)发布一季度业绩,归母净利润2688万元,同比下降34.79%
每周股票复盘:华纳药厂(688799)控股股东内部转让8.44%股份
证券之星 · 04-12
每周股票复盘:华纳药厂(688799)控股股东内部转让8.44%股份
华纳药厂(688799)披露控股股东增加一致行动人及股份内部转让过户完成公告,4月7日股价下跌2.16%
证券之星 · 04-07
华纳药厂(688799)披露控股股东增加一致行动人及股份内部转让过户完成公告,4月7日股价下跌2.16%
每周股票复盘:华纳药厂(688799)获新药注册证书
证券之星 · 03-29
每周股票复盘:华纳药厂(688799)获新药注册证书
3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股
证券之星 · 03-27
3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股
华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%
证券之星 · 03-24
华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%
加载更多
公司概况
公司名称:
湖南华纳大药厂股份有限公司
所属行业:
医药制造业
上市日期:
2021-07-13
主营业务:
湖南华纳大药厂股份有限公司的主营业务是化学药制剂、化学原料药和中药制剂的研发、生产与销售。公司的主要产品是胶体果胶铋干混悬剂、胶体果胶铋胶囊、枸橼酸铋钾胶囊、多库酯钠片、蒙脱石散、聚乙二醇4000散、吸入用乙酰半胱氨酸溶液、盐酸左沙丁胺醇雾化吸入溶液、吸入用硫酸沙丁胺醇溶液、吸入用异丙托溴铵溶液、富马酸福莫特罗吸入溶液、磷霉素氨丁三醇散、恩替卡韦颗粒、琥珀酸亚铁片、双氯芬酸钠缓释片、吗替麦考酚酯胶囊。公司荣获湖南省财政厅和国家税务总局湖南省税务局等颁发的“2024年度湖南省民营企业税收贡献百强”和“2024年度湖南省高新技术企业税收贡献百强”、浏阳经开区“2024年度创新发展奖”、“2024年度生物医药产业专项奖”、“2024年度市场开拓奖”、“2024年度智能升级奖”、“2024年度税收贡献奖”,入选由中国药科大学等指导、药智网等主办的2025PDI医药研发·创新大会暨中国药品研发百强榜发布会-2025中国化药研发实力前100强,获评每日经济新闻主办的第十四届中国上市公司峰会“大健康卓越竞争力上市公司”。
发行价格:
30.82
{"stockData":{"symbol":"688799","market":"SH","secType":"STK","nameCN":"华纳药厂","latestPrice":47.81,"timestamp":1780552214000,"preClose":47.18,"halted":0,"volume":3210713,"delay":0,"changeRate":0.0134,"floatShares":131000000,"shares":131000000,"eps":1.7054,"marketStatus":"交易中","change":0.63,"latestTime":"06-04 13:50:14","open":47.23,"high":48.99,"low":46.06,"amount":151000000,"amplitude":0.0621,"askPrice":47.76,"askSize":6,"bidPrice":47.71,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.7054,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780556400000},"marketStatusCode":2,"adr":0,"adjPreClose":47.18,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780536600000,1780543800000],[1780549200000,1780556400000]],"highLimit":51.9,"lowLimit":42.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":131320000,"isCdr":false,"pbRate":2.98,"roa":"--","peRate":28.034479,"roe":"1.28%","epsLYR":1.81,"committee":0.463415,"marketValue":6278000000,"turnoverRate":0.0244,"status":0,"floatMarketCap":6278000000},"requestUrl":"/m/hq/s/688799","defaultTab":"news","newsList":[{"id":"2640755908","title":"华纳药厂(688799)披露子公司原料药获得上市申请批准通知书,6月3日股价上涨0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640755908","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640755908?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:44","pubTimestamp":1780479863,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘,华纳药厂报收于47.18元,较前一交易日上涨0.81%,最新总市值为61.96亿元。该股当日开盘46.92元,最高47.18元,最低45.68元,成交额达9863.25万元,换手率为1.61%。近日,湖南华纳大药厂股份有限公司全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监督管理局签发的荧光素钠《化学原料药上市申请批准通知书》,并在CDE平台公示。荧光素钠为荧光素钠注射液的原料药,用于诊断性眼底和虹膜血管的荧光素血管造影检查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591660","title":"华纳药厂(688799.SH)子公司原料药荧光素钠获得上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591660","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640591660?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:55","pubTimestamp":1780390516,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,近日,公司全资子公司湖南华纳大药厂手性药物有限公司(简称“手性药物”)收到国家药品监督管理局签发的荧光素钠《化学原料药上市申请批准通知书》(通知书编号:2026YS00491),并在国家药品监督管理局药品审评中心(CDE)“原辅包登记信息”平台公示。荧光素钠是荧光素钠注射液的原料药。荧光素钠注射液适用于诊断性眼底和虹膜血管的荧光素血管造影检查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IPOS","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915249","title":"6月2日华纳药厂跌6.87%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915249?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:35","pubTimestamp":1780389309,"startTime":"0","endTime":"0","summary":"证券之星消息,6月2日华纳药厂跌6.87%,收盘报46.8元,换手率3.85%,成交量5.05万手,成交额2.4亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为4.99亿元,最新净值1.2733,较上一交易日下跌1.68%,近一年上涨3.13%。安信医药健康股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640307249","title":"华纳药厂(688799)披露2025年年度股东会决议公告,6月1日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640307249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640307249?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:50","pubTimestamp":1780307459,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,华纳药厂报收于50.25元,较前一交易日上涨0.06%,最新总市值为65.99亿元。该股当日开盘50.56元,最高52.65元,最低50.02元,成交额达1.38亿元,换手率为2.05%。近日,湖南华纳大药厂股份有限公司披露《2025年年度股东会决议公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100027716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640324659","title":"华纳药厂(688799.SH):法罗培南钠片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640324659","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640324659?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:51","pubTimestamp":1780303901,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,近日,公司收到国家药品监督管理局核准签发的法罗培南钠片《药品注册证书》。法罗培南钠片药品注册证书的取得进一步丰富了公司制剂产品品种,对优化公司产品结构有着积极意义。该药品注册证书的取得不会对公司近期业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华纳药厂(688799.SH):法罗培南钠片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639660441","title":"每周股票复盘:华纳药厂(688799)2025年年度股东会各项议案均获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2639660441","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639660441?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:50","pubTimestamp":1780170621,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,华纳药厂报收于50.22元,较上周的54.18元下跌7.31%。本周,华纳药厂5月25日盘中最高价报54.88元。华纳药厂当前最新总市值65.95亿元,在化学制药板块市值排名78/150,在两市A股市值排名2747/5207。本周关注点公司公告汇总:华纳药厂2025年年度股东会各项议案均获通过,无否决情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373294","title":"每周股票复盘:华纳药厂(688799)获贝前列素钠片注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373294?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:54","pubTimestamp":1779562451,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,华纳药厂报收于54.18元,较上周的57.44元下跌5.68%。本周,华纳药厂5月19日盘中最高价报59.88元。本周关注点来自公司公告汇总:贝前列素钠片获国家药监局药品注册证书,视同通过一致性评价。公司近日收到国家药品监督管理局核准签发的贝前列素钠片《药品注册证书》,药品规格为20μg、40μg,注册分类为化学药品4类,视同通过一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637839468","title":"华纳药厂(688799.SH):贝前列素钠片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637839468","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637839468?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:16","pubTimestamp":1779437766,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,近日,公司收到国家药品监督管理局核准签发的贝前列素钠片《药品注册证书》。据悉,贝前列素钠片用于改善慢性动脉闭塞性疾病引起的溃疡、间歇性跛行、疼痛和冷感等症状。公司贝前列素钠片按新注册分类化学药品4类获得药品注册证书,视同通过一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华纳药厂(688799.SH):贝前列素钠片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637394397","title":"华纳药厂(688799.SH)子公司通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2637394397","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637394397?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:12","pubTimestamp":1779437529,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,近日,公司全资子公司湖南华纳大药厂手性药物有限公司(简称“手性药物公司”)收到湖南省药品监督管理局签发的《药品GMP符合性检查告知书》,其位于长沙市望城区的重酒石酸去甲肾上腺素、盐酸异丙肾上腺素等2个原料药品种已通过药品生产质量规范符合性检查。本次通过药品GMP符合性检查,标志着手性药物公司可以正式生产和销售上述原料药产品,上述药品通过GMP符合性检查不会对公司近期业绩产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637327213","title":"华纳药厂(688799)披露2025年年度股东会变更会议召开地点的公告,5月21日股价下跌2.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637327213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637327213?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:41","pubTimestamp":1779374471,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,华纳药厂报收于54.21元,较前一交易日下跌2.55%,最新总市值为71.19亿元。该股当日开盘56.92元,最高57.45元,最低54.2元,成交额达1.95亿元,换手率为2.65%。近日,华纳药厂发布《关于2025年年度股东会变更会议召开地点的公告》。公告显示,公司原定于2026年5月29日召开2025年年度股东会,因会务安排调整,现场会议地点变更为湖南省长沙市望城区铜官循环经济工业基地湖南华纳大药厂致根制药有限公司会议室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635563718","title":"华纳药厂(688799)披露为全资孙公司提供担保的进展公告,5月14日股价下跌3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635563718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635563718?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:37","pubTimestamp":1778751456,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘,华纳药厂报收于58.5元,较前一交易日下跌3.31%,最新总市值为76.82亿元。华纳药厂于2026年5月14日发布《关于为全资孙公司提供担保的进展公告》。公告显示,公司于2026年4月17日召开董事会,审议通过2026年度为全资孙公司湖南华纳大药厂致根制药有限公司提供担保额度预计的议案,担保总额不超过8亿元,用于其生产基地建设、日常经营等资金需求。截至公告日,公司及控股子公司无对外担保,无逾期担保事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400031181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411902","title":"每周股票复盘:华纳药厂(688799)子公司原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411902","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411902?lang=zh_cn&edition=full","pubTime":"2026-05-10 01:33","pubTimestamp":1778347990,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,华纳药厂报收于61.99元,较上周的58.68元上涨5.64%。本周,华纳药厂5月8日盘中最高价报64.0元。本周关注点公司公告汇总:子公司贝前列素钠原料药获国家药监局上市申请批准。公司公告汇总湖南华纳大药厂股份有限公司全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监督管理局签发的贝前列素钠《化学原料药上市申请批准通知书》,并在CDE平台公示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633304435","title":"5月8日华纳药厂涨6.88%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633304435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633304435?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:26","pubTimestamp":1778228772,"startTime":"0","endTime":"0","summary":"证券之星消息,5月8日华纳药厂涨6.88%,收盘报61.99元,换手率5.35%,成交量7.03万手,成交额4.32亿元。重仓华纳药厂的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为4.99亿元,最新净值1.4218,较上一交易日上涨0.72%,近一年上涨36.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800028430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629088062","title":"华纳药厂终止向实控人方不超2.5亿定增 首季净利降35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629088062","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629088062?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:06","pubTimestamp":1776755165,"startTime":"0","endTime":"0","summary":" 华纳药厂于2026年4月17日召开第四届董事会第五次会议,审议通过了《关于终止公司2024年度向特定对象发行A股股票的议案》。 华纳药厂2025年5月13日披露的2024年度向特定对象发行A股股票预案(修订稿) 显示,本次向特定对象发行股票募集资金总额不超过25,000.00万元(含本数),扣除相关发行费用后的募集资金净额全部拟用于补充流动资金。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/21/20260421156727.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/21/20260421156727.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260421/32159778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628726370","title":"华纳药厂(688799.SH)发布一季度业绩,归母净利润2688万元,同比下降34.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628726370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628726370?lang=zh_cn&edition=full","pubTime":"2026-04-20 21:27","pubTimestamp":1776691670,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)披露2026年第一季度报告,报告期公司实现营收3.25亿元,同比下降3.48%;归母净利润2688万元,同比下降34.79%;扣非净利润2647万元,同比下降26.08%;基本每股收益0.20元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626124462","title":"每周股票复盘:华纳药厂(688799)控股股东内部转让8.44%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2626124462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626124462?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:18","pubTimestamp":1775927892,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,华纳药厂报收于61.99元,较上周的63.4元下跌2.22%。本周,华纳药厂4月9日盘中最高价报65.19元。本周关注点公司公告汇总:控股股东华纳医药向一致行动人华纳至臻协议转让所持公司8.44%股份,过户已完成。公司公告汇总湖南华纳大药厂股份有限公司控股股东华纳医药与一致行动人华纳至臻签署《股份转让协议》,将其持有的公司11,079,600股无限售条件流通股协议转让给华纳至臻。华纳至臻承诺受让股份后12个月内不减持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625956008","title":"华纳药厂(688799)披露控股股东增加一致行动人及股份内部转让过户完成公告,4月7日股价下跌2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625956008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625956008?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:06","pubTimestamp":1775570782,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,华纳药厂报收于62.03元,较前一交易日下跌2.16%,最新总市值为81.46亿元。近日,华纳药厂发布《关于控股股东增加一致行动人及在一致行动人内部协议转让股份过户完成的公告》。本次转让属于一致行动人之间的内部转让,不导致公司控股股东及实际控制人发生变化,合计持股比例不变,不触及要约收购。华纳至臻承诺受让股份后12个月内不减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623380414","title":"每周股票复盘:华纳药厂(688799)获新药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2623380414","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623380414?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:37","pubTimestamp":1774723029,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,华纳药厂报收于53.99元,较上周的43.81元上涨23.24%。本周,华纳药厂3月27日盘中最高价报56.0元。本周关注点来自公司公告汇总:华纳药厂获二甲双胍恩格列净片药品注册证书。来自股本股东变化:控股股东华纳医药拟向一致行动人华纳至臻转让8.44%股份。转让完成后,华纳医药持股比例由39.78%降至31.34%,华纳至臻持股8.44%。本次权益变动尚需上交所合规性确认及办理过户登记,存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622849847","title":"3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622849847?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:14","pubTimestamp":1774599278,"startTime":"0","endTime":"0","summary":"证券之星消息,3月27日华纳药厂涨10.05%创60日新高,收盘报53.99元,换手率9.32%,成交量12.23万手,成交额6.52亿元。重仓华纳药厂的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为3.62亿元,最新净值1.3167,较上一交易日下跌1.13%,近一年上涨38.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621930590","title":"华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621930590","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621930590?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:27","pubTimestamp":1774362444,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘,华纳药厂报收于44.78元,较前一交易日上涨1.8%,最新总市值为58.81亿元。近日,华纳药厂披露《关于控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告》。转让完成后,华纳医药持股比例由39.78%降至31.34%,华纳至臻持股8.44%。本次权益变动尚需上交所合规性确认及办理过户登记,存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400040013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780552221072,"stockEarnings":[{"period":"1week","weight":-0.101},{"period":"1month","weight":-0.196},{"period":"3month","weight":0.1244},{"period":"6month","weight":0.0011},{"period":"1year","weight":-0.1519},{"period":"ytd","weight":-0.0109}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0069},{"period":"3month","weight":-0.006},{"period":"6month","weight":0.0464},{"period":"1year","weight":0.2148},{"period":"ytd","weight":0.029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南华纳大药厂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8354人(较上一季度增加22.91%)","perCapita":"15719股","listingDate":"2021-07-13","address":"湖南省长沙市浏阳市生物医药园区","registeredCapital":"13132万元","survey":" 湖南华纳大药厂股份有限公司的主营业务是化学药制剂、化学原料药和中药制剂的研发、生产与销售。公司的主要产品是胶体果胶铋干混悬剂、胶体果胶铋胶囊、枸橼酸铋钾胶囊、多库酯钠片、蒙脱石散、聚乙二醇4000散、吸入用乙酰半胱氨酸溶液、盐酸左沙丁胺醇雾化吸入溶液、吸入用硫酸沙丁胺醇溶液、吸入用异丙托溴铵溶液、富马酸福莫特罗吸入溶液、磷霉素氨丁三醇散、恩替卡韦颗粒、琥珀酸亚铁片、双氯芬酸钠缓释片、吗替麦考酚酯胶囊。公司荣获湖南省财政厅和国家税务总局湖南省税务局等颁发的“2024年度湖南省民营企业税收贡献百强”和“2024年度湖南省高新技术企业税收贡献百强”、浏阳经开区“2024年度创新发展奖”、“2024年度生物医药产业专项奖”、“2024年度市场开拓奖”、“2024年度智能升级奖”、“2024年度税收贡献奖”,入选由中国药科大学等指导、药智网等主办的2025PDI医药研发·创新大会暨中国药品研发百强榜发布会-2025中国化药研发实力前100强,获评每日经济新闻主办的第十四届中国上市公司峰会“大健康卓越竞争力上市公司”。","listedPrice":30.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华纳药厂,688799,华纳药厂股票,华纳药厂股票老虎,华纳药厂股票老虎国际,华纳药厂行情,华纳药厂股票行情,华纳药厂股价,华纳药厂股市,华纳药厂股票价格,华纳药厂股票交易,华纳药厂股票购买,华纳药厂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}